Biotechnology
+243
Clinical Research (2025 Update)
Novel therapeutic modalities lead the way, from AI-driven drug discovery and personalized medicine to gene editing and radioligand therapies for aggressive cancers. Platforms improving research and clinical trials are also prominent.
👋🏼 Hey there! Bounce Watch here — I'm gathering key information from Clinical Research list.
Real-Time Scouting Assistant
6 highlights have been identified across this list.
Mentioned on News
2
Recently Funded
1
Open Positions
3
Latest Highlights
Explore Clinical Research featuring 250 Companies in Biotechnology Industry
|
|
|
|||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
DBV Technologies | - | On a mission to advance epicutaneous immunotherapy using our innovative technolo... | DBV Technologies is a global clinical stage biopharmaceutical company founded by... | - |
France
|
- | France (HQ) + 1 | 2002 | Biopharma, Biotechnology +1 | [email protected] |
1
Low
|
174
|
5.6K (-47%) | 2 years ago | Post Ipo Equity | 7 | 243.3M | 16598 | 5 months ago | |
|
|
|
Cullinan Oncology | - | Mining for tomorrow’s cures | Cullinan Oncology is dedicated to creating new standards of care for patients wi... | - |
United States
|
Cambridge | United States (HQ) | 2017 | Biopharma, Biotechnology +1 | [email protected] |
1
Low
|
88
|
637 (-36%) | 1 year ago | Post Ipo Equity | 5 | 669.7M | 37870 | 4 b6p H3J | |
|
|
|
Science 37 | - | Access More Patients. Enroll Faster. | Science 37’s mission is to accelerate clinical research by enabling universal tr... | - |
United States
|
Morrisville | United States (HQ) | 2014 | Biotechnology, Health Care | [email protected] |
1
Low
|
322
|
17.7K (-3%) | 3 years ago | Post Ipo Equity | 6 | 347.5M | 26286 | 5 months ago | |
|
|
|
CENTOGENE | - | The essential biodata life science partner for rare and neurodegenerative diseas... | CENTOGENE’s mission is to provide data-driven, life-changing answers to patients... | - |
Germany
|
Rostock | Germany (HQ) + 4 | 2006 | Biotechnology, Health Care | [email protected] |
1
Low
|
428
|
20.3K (-4%) | 1 year ago | Post Ipo Debt | 6 | 224.9M | 33160 | 5 months ago | |
|
|
|
D2V Clinical | - | When it comes to oncology, hematology and rare disease drug development, we know... |
Your milestones, our mission Founded to expedite biopharmaceutical value creatio... |
- |
United States
|
Raleigh | United States (HQ) + 6 | 2019 | Biotechnology, Health Care | [email protected] |
1
Low
|
26
|
329 | 2 years ago | Series A | 3 | 10.0M | 831 | 5 months ago | |
|
|
|
NephroSant, Inc. | - | Kidney Health Redefined | Kidney transplantation is the treatment of choice for patients with end-stage ki... | - |
United States
|
San Mateo | United States (HQ) | 2017 | Biotechnology, Health Care | - |
1
Low
|
4
|
3.9K (328%) | 4 years ago | Series A | 1 | 16.0M | 2057 | 2 years ago | |
|
|
|
NeRRe Therapeutics Ltd | - | Developing a breakthrough treatment for the disabling chronic cough associated w... | NeRRe Therapeutics is developing orvepitant, a neurokinin (NK)-1 receptor antago... | - |
United Kingdom
|
Stevenage | United Kingdom (HQ) | 2012 | Biotechnology, Health Care | [email protected] |
1
Low
|
9
|
666 (72%) | 3 years ago | Series B | 3 | 74.6M | 899 | 1 year ago | |
|
|
|
Boca Biolistics, LLC | - | Driving Science Forward | We are a one-of-a-kind resource built for the future of life science research.... | - |
United States
|
Pompano Beach | United States (HQ) + 1 | 2005 | Biotechnology, Life Sciences | [email protected] |
1
Low
|
30
|
2.1K (-56%) | 2 years ago | Private Equity | 1 | 25.0M | 1344 | 5 months ago | |
|
|
|
CryoCrate LLC | - | Innovate cell and tissue cryopreservation for biomedical and biological industri... | In today’s market, there are numerous cell and tissues that (a) cannot be cryopr... | - |
United States
|
Columbia | United States (HQ) | 2012 | Biotechnology | - |
1
Low
|
3
|
221 (-84%) | 8 years ago | Convertible Note | 1 | Unknown | 69 | 9 yFC z89 | |
|
|
|
Sensei Bio | - | We follow the immune system’s teachings to discover new treatments that inspire... | Sensei Biotherapeutics is an immuno-oncology company that is dedicated to unders... | - |
United States
|
Rockville | United States (HQ) + 1 | 1999 | Biotechnology, Health Care +2 | [email protected] |
1
Low
|
32
|
3.5K (35%) | 4 years ago | Series B | 2 | 58.5M | 3327 | 5 months ago | |
|
|
|
Beyond Air® | - | The Magic of Breathing® |
AIT Therapeutics, commencing June 26, 2019 is named Beyond Air®. https://www.be... |
- |
United States
|
Garden City | United States (HQ) + 1 | 2011 | Biopharma, Biotechnology +3 | [email protected] |
1
Low
|
79
|
3.9K (160%) | 1 year ago | Post Ipo Equity | 6 | 85.2M | 5618 | 4 months ago | |
|
|
|
SurgeCare | - | Shaping the future of precision health by decrypting the immune system. | We believe that fingerprinting the immune system can be a game-changer when it c... | - |
France
|
- | France (HQ) + 1 | 2021 | AI, Analytics +4 | [email protected] |
1
Low
|
19
|
371 (1%) | 1 year ago | Seed | 4 | 10.7M | 1878 | 6 months ago | |
|
|
|
TRACON Pharmaceuticals | - | Our Goal is to be the Leader in the Development of Targeted Therapies for Patien... | TRACON is a biopharmaceutical company focused on the development and commerciali... | - | - | - | - | 2006 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
19
|
2.5K (-14%) | 2 years ago | Post Ipo Debt | 10 | 113.0M | 1443 | 1 year ago | |
|
|
|
ClinChoice昆翎 | Not active anymore | Accelerating the development and commercialization of innovative drugs and devic... | ClinChoice昆翎是一家全球临床CRO公司，以“立足中国、服务全球”为己任，充分运用我们... | - |
China
|
- | China (HQ) | 1995 | Biotechnology, Health Care +1 | [email protected] |
-1
N/A
|
91
|
10.3K (72%) | 2 years ago | Series E | 7 | 212.0M | 1655 | 4 years ago | |
|
|
|
OncoDiag | - | Innovative Solutions for Cancer Diagnostics | OncoDiag est une société spécialisée dans le développement et la commercialisati... | - | - | - | - | 2013 | Biotechnology, Health Care | [email protected] |
1
Low
|
6
|
1.2K (-25%) | 4 years ago | Series A | 4 | 4.1M | 943 | 1 year ago | |
|
|
|
BioAtla, Inc. | - | - | BioAtla is a protein therapeutic company that uses discovery and evolution to de... | - |
United States
|
San Diego | United States (HQ) | 2007 | Biotechnology, Health Care | [email protected] |
1
Low
|
69
|
7.7K (-17%) | 2 years ago | Post Ipo Equity | 6 | 326.5M | 5497 | 5 months ago | |
|
|
|
Ultima Genomics | - | Unleashing the power of genomics at scale | Ultima Genomics is unleashing the power of genomics at scale. Our mission is to... | - |
United States
|
Fremont | United States (HQ) | 2016 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
305
|
5.8K | 2 years ago | Series Unknown | 1 | 600.0M | 18690 | 5 months ago | |
|
|
|
Sequoia Sciences | - | Pioneering medical advancements to combat bacterial infections and cancers for a... | Sequoia Sciences is a pharmaceutical company focused on discovering and developi... | - | - | - | - | 1999 | Biotechnology, Health and Wellness +1 | [email protected] |
1
Low
|
295
|
1.3K (18%) | 4 years ago | Seed | 2 | 72.0K | 39 | 2 VMJ 43Q | |
|
|
|
Henlius | - | Reliable Quality · Affordable Innovation | Henlius is a rapidly growing biopharmaceutical provider that develops, manufactu... | - |
China
|
Shanghai | China (HQ) + 1 | 2010 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
445
|
17.3K (-38%) | 6 years ago | Series Unknown | 3 | 346.0M | 11126 | 4 months ago | |
|
|
|
Sky Medical Technology | - | Sky Medical develops bioelectronic devices to treat a wide range of acute and ch... | Sky Medical develops bioelectronic devices integrated with OnPulse neuromodulati... | - |
United Kingdom
|
High Wycombe | United Kingdom (HQ) | 2006 | Biotechnology, Health Care | - |
1
Low
|
7
|
5.1K (510%) | 7 years ago | Secondary Market | 8 | 59.6M | 1016 | 4 months ago | |
|
|
|
TheraCryf | - | - | TheraCryf plc is a clinical stage therapeutics company developing a new generati... | - |
United Kingdom
|
Wilmslow | United Kingdom (HQ) | 2007 | Biotechnology, Pharmaceutical | [email protected] |
1
Low
|
6
|
1.7K | 4 years ago | Post Ipo Equity | 5 | 16.4M | 1330 | 5 months ago | |
|
|
|
KBP Biosciences | - | At KBP we are consistently reminded that patient care is the end goal of what we... | At KBP we are consistently reminded that patient care is the end goal of what we... | - |
United States
|
Princeton | United States (HQ) + 1 | 2007 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
40
|
1.4K (40%) | 7 years ago | Series A | 1 | 76.0M | 1776 | 7 years ago | |
|
|
|
Spear Bio | - | The first homogeneous immunoassay platform offering unmatched sensitivity with s... | Spear Bio, founded in 2021, is a well-funded and rapidly growing start-up headqu... | - |
United States
|
Boston | United States (HQ) | 2021 | Biotechnology, Health Care | - |
1
Low
|
32
|
1.9K (73%) | 1 year ago | Seed | 1 | Unknown | 3070 | 5 months ago | |
|
|
|
Gossamer Bio | - | Vision * Connection * Innovation | Gossamer Bio is a San Diego-based clinical-stage biopharmaceutical company focus... | - |
United States
|
San Diego | United States (HQ) + 1 | 2017 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
159
|
738 (-100%) | 1 year ago | Post Ipo Equity | 5 | 812.0M | 10806 | 5 months ago | |
|
|
|
Complexa | - | Advancing therapeutic innovation in human cell signaling for inflammation, fibro... | Complexa, a clinical-stage biopharmaceutical company based in Berwyn, Pennsylvan... | - | - | - | - | 2008 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
142
|
552 | 7 years ago | Series C | 8 | 86.9M | 13253 | 4 Afx 9JP | |
|
|
|
Olema Oncology | - | Olema Oncology is a cancer medicines company dedicated to impacting breast cance... | - |
United States
|
San Francisco | United States (HQ) + 1 | 2007 | Biopharma, Biotechnology +2 | [email protected] |
1
Low
|
114
|
4.4K (10%) | 1 year ago | Post Ipo Equity | 5 | 455.1M | 8621 | 5 months ago | ||
|
|
|
Clinical Maestro | - | Revolutionizing Clinical Trial Budgeting, Outsourcing and Vendor Management | Clinical Maestro® by Strategikon is an end-to-end elegant cloud-based platform t... | - |
United States
|
San Rafael | United States (HQ) | 2017 | B2B, Biotechnology +2 | [email protected] |
1
Low
|
31
|
1.5K | 2 years ago | Grant | 4 | 25.0K | 1980 | 5 months ago | |
|
|
|
VisiCELL Medical Inc. | - | GPS for cell therapy | Visicell Medical Inc. was founded by a team of passionate scientist, engineer, a... | - |
United States
|
San Diego | United States (HQ) | 2012 | Biotechnology | - |
1
Low
|
12
|
958 (32%) | 3 years ago | Grant | 2 | 255.5K | 277 | 6 months ago | |
|
|
|
Gritstone bio | - | A clinical-stage biotech company that aims to develop the world’s most potent va... | Gritstone bio brings together a group of distinguished scientific founders and a... | - |
United States
|
Emeryville | United States (HQ) + 1 | 2015 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
131
|
3.3K (-43%) | 1 year ago | Post Ipo Equity | 10 | 604.1M | 11416 | 5 months ago | |
|
|
|
Mariana Oncology | - | Driven to Cure: Delivering innovative, safe and effective radiopharmaceutical ca... | Mariana Oncology, a Novartis company, is a fully integrated next generation radi... | - | - | - | - | 2021 | Biopharma, Biotechnology +1 | - |
1
Low
|
75
|
4.1K (-2%) | 1 year ago | Series B | 2 | 250.0M | 6455 | 5 months ago | |
|
|
|
Syros Pharmaceuticals | - | By redefining the power of small molecules to control gene expression, we aim to... | Syros is committed to developing new standards of care for the frontline treatme... | - |
United States
|
Cambridge | United States (HQ) | 2012 | Biotechnology, Life Sciences +1 | [email protected] |
1
Low
|
88
|
7.5K (-9%) | 1 year ago | Post Ipo Equity | 11 | 620.5M | 25158 | 6 months ago | |
|
|
|
Alpheus Medical, Inc | - | Changing the way cancer is treated. | Alpheus Medical, Inc, is a privately held company based in Oakdale, Minnesota, d... | - |
United States
|
Oakdale | United States (HQ) | 2021 | Biotechnology, Health Care | [email protected] |
1
Low
|
9
|
650 (-100%) | 2 years ago | Series A | 2 | 30.0M | 374 | 5 months ago | |
|
|
|
resistanceBio | - | Harnessing evolution to overcome treatment-resistant cancer. | Helping patients fight treatment-resistant cancer. resistanceBio can discover an... | - |
United States
|
San Carlos | United States (HQ) | 2019 | Biotechnology, Health Care | [email protected] |
1
Low
|
5
|
1.4K (-26%) | 1 year ago | Series Unknown | 5 | 24.8M | 1268 | 1 year ago | |
|
|
|
Cirius Therapeutics | - | Pioneering the future of liver and metabolic disease treatment with innovative i... | Cirius Therapeutics is a clinical-stage company focused on developing treatments... | - | - | - | - | 2015 | Biopharma, Biotechnology +3 | - |
1
Low
|
376
|
1.3K (-7%) | 6 years ago | Series A | 2 | 49.0M | 81647 | 1 QUt XoE | |
|
|
|
Rakuten Medical | - | Rakuten Medical, Inc. is a global biotechnology company in pursuit of conquering... | Rakuten Medical, Inc. is a global biotechnology company developing and commercia... | - |
United States
|
San Diego | United States (HQ) + 4 | 2010 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
120
|
18.3K (24%) | 1 year ago | Series E | 10 | 737.6M | 9251 | 6 months ago | |
|
|
|
Topica Pharmaceuticals | Not active anymore | Developing the first highly effective and safe topical therapy for onychomycosis... | TOPICA Pharmaceuticals, Inc. is a privately held clinical research stage company... | - | - | - | - | 2004 | Biotechnology, Medical Devices +1 | - |
-1
N/A
|
654
|
319 | 11 years ago | Series Unknown | 3 | 58.5M | 25454 | 6 wVu TQS | |
|
|
|
Inmedix Inc | - | Bringing accurate and safe HRV meeting FDA standards to clinicians. | Inmedix is working to bring a point-of-service diagnostic to medicine applying h... | - |
United States
|
- | United States (HQ) + 1 | 2017 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
4
|
2.8K (217%) | 2 years ago | Seed | 6 | 9.3M | 116 | 8 hBj rtU | |
|
|
|
Aravax | - | - | Aravax is a clinical stage biotechnology company developing a novel peptide-base... | - |
Australia
|
Melbourne | Australia (HQ) | 2015 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
11
|
1.6K (23%) | 1 year ago | Series B | 3 | 42.2M | 967 | 5 months ago | |
|
|
|
ImpriMed, Inc. | - | AI-driven Personalized Medicine for Cancer Care | ImpriMed, founded in 2017 in Silicon Valley, is a leading precision medicine sta... | - |
United States
|
Mountain View | United States (HQ) | 2017 | AI, Biotechnology +1 | - |
1
Low
|
41
|
51.7K (23%) | 1 year ago | Series A | 5 | 34.7M | 4148 | 1 year ago | |
|
|
|
Sanguine Biosciences | - | Bridging the gap between researchers and patients | Sanguine Biosciences is accelerating personalized medicine by empowering patient... | - |
United States
|
Woburn | United States (HQ) | 2010 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
116
|
11.3K (-3%) | 1 year ago | Debt Financing | 8 | 12.2M | 9169 | 4 months ago | |
|
|
|
Genomics | - | Transforming health, healthcare and drug discovery through the power of genomics... | We are a pioneering healthcare company that aims to transform health through the... | - |
United Kingdom
|
Oxford | United Kingdom (HQ) + 3 | 2014 | Biopharma, Biotechnology +3 | [email protected] |
1
Low
|
166
|
16.5K | 1 year ago | Series C | 8 | 135.4M | 12410 | 3 months ago | |
|
|
|
Modifi Bio | - | Modifying DNA to Eradicate Cancer | A bold and innovative biotech, Modifi Bio is developing a novel oncology therape... | - | - | - | - | 2021 | Biotechnology, Health and Wellness | [email protected] |
1
Low
|
10
|
932 | 1 year ago | Seed | 3 | 13.1M | 2162 | 6 months ago |